Evofem Biosciences, Inc. (EVFM) Margin Analysis - Discounting Cash Flows
EVFM
Evofem Biosciences, Inc.
EVFM (OTC)

Years and Quarters

Years

Years

The number of historical years used to render the annual chart and tables.

Quarters

Quarters

The number of historical quarters used to render the quarterly chart and tables.

Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (example: Net Income Margin = Net Income / Revenue).

This analysis provides annual and quarterly sections for reporting key financial margins.

Annual Section

The annual section uses annual data to calculate margins and growth rates.

Monetary values in USD

amounts except #

LTM
Mar 20
2025
Dec 31
2024
Dec 31
2023
Dec 31
2022
Dec 31
Revenue 20.18 20.18 19.36 18.22 16.84
Revenue Growth Rate 0% 4.23% 6.29% 8.2% 104.2%
Cost of Revenue 5.12 5.12 3.83 6.51 4.42
Gross Profit 15.07 15.07 15.53 11.71 12.42
Gross Margin 74.65% 74.65% 80.2% 64.26% 73.78%
Operating Income 1.44 1.44 -7.68 -17.85 -84.12
Operating Margin 7.13% 7.13% -39.64% -97.96% -499.6%
Net Income 0.391 0.391 -8.86 52.98 -76.7
Net Margin 1.94% 1.94% -45.76% 290.8% -455.5%

Monetary values in USD

amounts except #

LTM
Mar 20
2025
Dec 31
2024
Dec 31
2023
Dec 31
2022
Dec 31
Revenue 20.18 20.18 19.36 18.22 16.84
Cash from Operating Activities -1.99 -1.99 -3.88 -8.97 -70.41
Cash from Operating Activities Margin -9.87% -9.87% -20.06% -49.23% -418.2%
Free Cash Flow -2 -2 -3.9 -8.97 -70.75
Free Cash Flow Margin -9.89% -9.89% -20.14% -49.25% -420.2%
Depreciation and Amortization 0.579 0.518 0.756 1.78 2.05
Depreciation and Amortization Margin 2.87% 2.57% 3.9% 9.78% 12.15%
Capital Expenditure -0.005 -0.005 -0.014 -0.004 -0.341
Capital Expenditure Margin -0.025% -0.025% -0.072% -0.022% -2.02%

Annual Chart

Monetary values in USD

Quarterly Section

The quarterly section uses quarterly data to calculate margins and growth rates.

Monetary values in USD

amounts except #

2025 (Q4)
Dec 31
2025 (Q3)
Sep 30
2025 (Q2)
Jun 30
2025 (Q1)
Mar 31
2024 (Q4)
Dec 31
2024 (Q3)
Sep 30
2024 (Q2)
Jun 30
2024 (Q1)
Mar 31
2023 (Q4)
Dec 31
Revenue 9.56 4.95 4.83 0.845 7.1 4.5
Revenue Growth Rate 93.07% 2.63% 471% -88.11% 58.01%
Cost of Revenue 3.01 0.985 0.755 0.365 1.51 0.869
Gross Profit 6.55 3.97 4.07 0.48 5.59 3.63
Gross Margin 68.51% 80.11% 84.35% 56.8% 78.72% 80.67%
Operating Income 3.35 -0.982 -1.25 0.327 -1 -2.44
Operating Margin 34.99% -19.83% -25.93% 38.7% -14.12% -54.27%
Net Income 2.79 -1.57 -1.78 0.956 -3.04 -2.37
Net Margin 29.16% -31.68% -36.97% 113.1% -42.75% -52.6%

Monetary values in USD

amounts except #

2025 (Q4)
Dec 31
2025 (Q3)
Sep 30
2025 (Q2)
Jun 30
2025 (Q1)
Mar 31
2024 (Q4)
Dec 31
2024 (Q3)
Sep 30
2024 (Q2)
Jun 30
2024 (Q1)
Mar 31
2023 (Q4)
Dec 31
Revenue 9.56 4.95 4.83 0.845 7.1 4.5
Cash from Operating Activities 0.031 0.336 -2.92 0.56 -2.41 -0.459
Cash from Operating Activities Margin 0.324% 6.78% -60.5% 66.27% -33.9% -10.21%
Free Cash Flow 0.028 0.336 -2.92 0.56 -2.41 -0.459
Free Cash Flow Margin 0.293% 6.78% -60.54% 66.27% -33.9% -10.21%
Depreciation and Amortization 0.155 0.023 0.135 0.266 0.361 0.376
Depreciation and Amortization Margin 1.62% 0.464% 2.8% 31.48% 5.08% 8.36%
Capital Expenditure -0.003 0 -0.002 0 0 0
Capital Expenditure Margin -0.031% 0% -0.041% 0% 0% 0%

Quarterly Chart

Monetary values in USD

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program